Cargando…

Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer

The prognosis-associated genes of urinary bladder cancer have been systematically investigated in the Pathology Atlas project based on The Cancer Genome Atlas data. However, the biological functions of most genes in bladder cancer remain unknown. The present study investigated the biological functio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuanbin, Xu, Ting, Xie, Fei, Wang, Liping, Liang, Zhijuan, Li, Dan, Liang, Ye, Zhao, Kaidong, Qi, Xiangjie, Yang, Xuecheng, Jiao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709834/ https://www.ncbi.nlm.nih.gov/pubmed/33200223 http://dx.doi.org/10.3892/or.2020.7853

Ejemplares similares

Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer
por: Wang, Liping, et al.
Publicado: (2021)

Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
por: Liang, Ye, et al.
Publicado: (2020)

The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ
por: Wang, Liping, et al.
Publicado: (2018)

Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis
por: Sun, Ningchuan, et al.
Publicado: (2019)

Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1
por: Zhang, Zhao, et al.
Publicado: (2023)

Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2021)

Correction: Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
por: Yu, Yongbo, et al.
Publicado: (2023)

Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer
por: Shen, Chengquan, et al.
Publicado: (2020)

KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma
por: Zhao, Kaidong, et al.
Publicado: (2022)

Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression
por: Zhang, Zhilei, et al.
Publicado: (2023)

Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies
por: Ma, Guofeng, et al.
Publicado: (2021)

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
por: Ma, Guofeng, et al.
Publicado: (2022)

C3, C3AR1, HLA-DRA, and HLA-E as potential prognostic biomarkers for renal clear cell carcinoma
por: Chu, Guangdi, et al.
Publicado: (2020)

Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2021)

Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2022)

Biological Functions and Prognostic Value of Ferroptosis-Related Genes in Bladder Cancer
por: Yi, Kezhen, et al.
Publicado: (2021)

Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Muscle-Invasive Bladder Cancer After Radical Cystectomy
por: Zhao, Ming, et al.
Publicado: (2020)

Bioinformatic analysis and machine learning to identify the diagnostic biomarkers and immune infiltration in adenomyosis
por: Liu, Dan, et al.
Publicado: (2023)

Construction of a prognostic model for radical esophagectomy based on immunohistochemical prognostic markers combined with clinicopathological factors
por: Wang, Bo, et al.
Publicado: (2023)

A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer
por: Fan, Zhongyuan, et al.
Publicado: (2019)

CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)
por: Oldenburg, Darby, et al.
Publicado: (2016)

Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas
por: Zhou, Yu‐Wen, et al.
Publicado: (2021)

Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer
por: Zhao, Yang, et al.
Publicado: (2021)

Novel Pyroptosis-Related Gene Signatures Identified as the Prognostic Biomarkers for Bladder Carcinoma
por: You, Jia, et al.
Publicado: (2022)

Single-cell profiling of murine bladder cancer identifies sex-specific transcriptional signatures with prognostic relevance
por: Abdel-Hafiz, Hany A., et al.
Publicado: (2023)

High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer
por: Zhang, Xuezhou, et al.
Publicado: (2022)

Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
por: AZhaTi, BaiHeTiYa, et al.
Publicado: (2022)

Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade
por: Asai, Akihiro, et al.
Publicado: (2017)

Tumours of the Bladder: Their Pathology and Diagnosis
Publicado: (1892)

Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma
por: Han, Shuxia, et al.
Publicado: (2022)

T1 bladder carcinoma with variant histology: pathological features and clinical significance
por: Lopez-Beltran, Antonio, et al.
Publicado: (2022)

Prognostic value and potential biological functions of ferroptosis-related gene signature in bladder cancer
por: Wang, Yutong, et al.
Publicado: (2022)

Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma
por: Deng, Chao, et al.
Publicado: (2021)

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
por: Zeng, Shuxiong, et al.
Publicado: (2017)

Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancer
por: Liao, Yihao, et al.
Publicado: (2021)

Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer
por: Li, Haimeng, et al.
Publicado: (2021)

Novel Biologic Therapies for Thymic Epithelial Tumors
por: Chen, Yuanbin, et al.
Publicado: (2014)

Narrative review: update on immunotherapy and pathological features in patients with bladder cancer
por: Aurilio, Gaetano, et al.
Publicado: (2021)

Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
por: Liu, Guohong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ehnh4iqvqhgu2n97o01ti8qum2